Phio Pharmaceuticals

PHIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$9.295 M

$0.80 -8.02%

Close of 6 Nov 2026

As of 6 Nov 2026, Phio Pharmaceuticals (PHIO) has a market capitalization of $9.29M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$8.70M

Loss-making

Shares outstanding

11,951,632

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#417Aspire-LakewoodASBP$9.58M
#418GT BiopharmaGTBP$9.44M
#419Phio PharmaceuticalsPHIO$9.29M
#420Moleculin BiotechMBRX$9.16M
#421Curanex PharmaceuticalsCURX$9.06M

Insiders buying

All insider buying →

2 open-market purchases by officers and directors of Phio Pharmaceuticals, worth $27.7K. Grants and option exercises are excluded.

Ronald Todd Plott$17.1K
15,000 shares at $1.14 on 19 Aug 2026 · filed 20 Aug 2026
Robert J. BittermanChairman, Pres. & CEO$10.6K
10,000 shares at $1.06 on 18 Aug 2026 · filed 19 Aug 2026

What if Phio Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,430,599

Per share 3,037,869× higher

Bitcoin $1.53T

$131,515.46

Per share 164,374× higher

Apple $5.02T

$431,752.99

Per share 539,624× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Phio Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.